
Overview
Paul Swiecicki is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan.
Dr. Swiecicki is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, Laryngeal Cancer, and Oral Squamous Cell Carcinoma.
Dr. Swiecicki is board certified in Medical Oncology. He is actively involved in clinical research, co-authoring 101 peer reviewed articles and participating in 13 clinical trials. Dr. Swiecicki is currently accepting new patients.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 E Medical Center Dr Fl 2, Ann Arbor, MI 48109
1500 E Medical Center Dr, Floor 1 Reception A, Ann Arbor, MI 48109
Ann Arbor, MI 48109
Additional Areas of Focus
Dr. Swiecicki has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
13 Clinical Trials
Rogel Cancer Center
Rashmi Chugh is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, and Ewing Sarcoma. Dr. Chugh is currently accepting new patients.
Rogel Cancer Center
Scott Schuetze is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Schuetze is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Liposarcoma, Adult Soft Tissue Sarcoma, Angiosarcoma, and Myxoid Liposarcoma. Dr. Schuetze is currently accepting new patients.
Rogel Cancer Center
Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Urothelial Cancer, Prostate Cancer, Nephrectomy, and Orchiectomy. Dr. Vaishampayan is board certified in Medical Oncology. Dr. Vaishampayan is currently accepting new patients.
Frequently Asked Questions about Dr. Paul L. Swiecicki
How do I make an appointment with Dr. Paul L. Swiecicki?
You can book an appointment with Dr. Paul L. Swiecicki by calling their office at 734-936-8051. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Paul L. Swiecicki a top-rated expert for Head and Neck Squamous Cell Carcinoma (HNSCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Paul L. Swiecicki is classified as an Elite expert for Head and Neck Squamous Cell Carcinoma (HNSCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Paul L. Swiecicki specialize in?
While Dr. Paul L. Swiecicki is a Oncology, they have specific expertise in Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, and Laryngeal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Paul L. Swiecicki participate in research or clinical trials?
Yes. Dr. Paul L. Swiecicki has published 101 articles and abstracts on conditions like Head and Neck Squamous Cell Carcinoma (HNSCC). You can view a list of Dr. Paul L. Swiecicki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Paul L. Swiecicki accept my insurance?
Dr. Paul L. Swiecicki accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 734-936-8051 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Distinguished
- Adenoid Cystic CarcinomaDr. Swiecicki isDistinguished. Learn about Adenoid Cystic Carcinoma.
- Laryngeal CancerDr. Swiecicki isDistinguished. Learn about Laryngeal Cancer.
- Oral Squamous Cell CarcinomaDr. Swiecicki isDistinguished. Learn about Oral Squamous Cell Carcinoma.
- Throat CancerDr. Swiecicki isDistinguished. Learn about Throat Cancer.
- Advanced
- Acinic Cell Carcinoma of Salivary Glands
- Epithelial-Myoepithelial CarcinomaDr. Swiecicki isAdvanced. Learn about Epithelial-Myoepithelial Carcinoma.
- GliomaDr. Swiecicki isAdvanced. Learn about Glioma.
- Nasopharyngeal CarcinomaDr. Swiecicki isAdvanced. Learn about Nasopharyngeal Carcinoma.
- Olfactory NeuroblastomaDr. Swiecicki isAdvanced. Learn about Olfactory Neuroblastoma.
- Polymorphous Low Grade AdenocarcinomaDr. Swiecicki isAdvanced. Learn about Polymorphous Low Grade Adenocarcinoma.
- Salivary Gland TumorsDr. Swiecicki isAdvanced. Learn about Salivary Gland Tumors.
- Sinus CancerDr. Swiecicki isAdvanced. Learn about Sinus Cancer.
- Squamous Cell Skin CarcinomaDr. Swiecicki isAdvanced. Learn about Squamous Cell Skin Carcinoma.
- TeratocarcinosarcomaDr. Swiecicki isAdvanced. Learn about Teratocarcinosarcoma.
- Tongue CancerDr. Swiecicki isAdvanced. Learn about Tongue Cancer.
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Swiecicki isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Basal Cell Skin CancerDr. Swiecicki isExperienced. Learn about Basal Cell Skin Cancer.
- Bone TumorDr. Swiecicki isExperienced. Learn about Bone Tumor.
- Chromophobe Renal Cell CarcinomaDr. Swiecicki isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Swiecicki isExperienced. Learn about Clear Cell Sarcoma.
- Colorectal CancerDr. Swiecicki isExperienced. Learn about Colorectal Cancer.
- Ear CancerDr. Swiecicki isExperienced. Learn about Ear Cancer.
- Eccrine PorocarcinomaDr. Swiecicki isExperienced. Learn about Eccrine Porocarcinoma.
- EGFR Positive Lung CancerDr. Swiecicki isExperienced. Learn about EGFR Positive Lung Cancer.
- Ewing SarcomaDr. Swiecicki isExperienced. Learn about Ewing Sarcoma.
- Familial Colorectal CancerDr. Swiecicki isExperienced. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Swiecicki isExperienced. Learn about Familial Pancreatic Cancer.
- Familial Wilms Tumor 2Dr. Swiecicki isExperienced. Learn about Familial Wilms Tumor 2.
- Gastroesophageal Junction CancerDr. Swiecicki isExperienced. Learn about Gastroesophageal Junction Cancer.
- Large-Cell Lung CarcinomaDr. Swiecicki isExperienced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Swiecicki isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Swiecicki isExperienced. Learn about Lung Cancer.
- Lymphofollicular HyperplasiaDr. Swiecicki isExperienced. Learn about Lymphofollicular Hyperplasia.
- Lynch SyndromeDr. Swiecicki isExperienced. Learn about Lynch Syndrome.
- MelanomaDr. Swiecicki isExperienced. Learn about Melanoma.
- Metastatic Brain TumorDr. Swiecicki isExperienced. Learn about Metastatic Brain Tumor.
- Neuroendocrine TumorDr. Swiecicki isExperienced. Learn about Neuroendocrine Tumor.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Swiecicki isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Opioid Induced ConstipationDr. Swiecicki isExperienced. Learn about Opioid Induced Constipation.
- Pancreatic CancerDr. Swiecicki isExperienced. Learn about Pancreatic Cancer.
- Pleuropulmonary BlastomaDr. Swiecicki isExperienced. Learn about Pleuropulmonary Blastoma.
- Posterior Fossa TumorDr. Swiecicki isExperienced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Swiecicki isExperienced. Learn about Primitive Neuroectodermal Tumor (PNET).
- Pseudomyxoma PeritoneiDr. Swiecicki isExperienced. Learn about Pseudomyxoma Peritonei.
- Renal Cell Carcinoma (RCC)Dr. Swiecicki isExperienced. Learn about Renal Cell Carcinoma (RCC).
- Secondary Adrenal InsufficiencyDr. Swiecicki isExperienced. Learn about Secondary Adrenal Insufficiency.
- Small Cell Lung Cancer (SCLC)Dr. Swiecicki isExperienced. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Swiecicki isExperienced. Learn about Squamous Cell Lung Carcinoma.
- Stomach CancerDr. Swiecicki isExperienced. Learn about Stomach Cancer.
- Wilms TumorDr. Swiecicki isExperienced. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor SyndromesDr. Swiecicki isExperienced. Learn about WT1-Related Wilms Tumor Syndromes.


